Clinical trial
A Phase 1 Study of LY2624587 in Patients With Advanced Cancer
NCT01139788 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of LY2624587 in Patients With Advanced Cancer
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- November 30, 2011
- Enrollment
- 56 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic cancer